chelation therapy

Chelation therapy offers small, if any, benefit for heart disease

Chelation therapy removes metals that have built up in the body. It is an FDA-approved way to treat mercury, lead, and other types of heavy-metal poisoning, as well as for iron overload (hemochromatosis) and some types of anemia. It has also been touted as an alternative therapy that can cure heart disease. Results from the 10-year, $31 million Trial to Assess Chelation Therapy (TACT) show that it slightly reduced the risk of heart problems in heart attack survivors. Proponents of chelation therapy will say this proves what they’ve been preaching. But the editors of JAMA, which published the trial results say that the findings “should serve to dissuade responsible practitioners from providing or recommending chelation therapy for patients with coronary disease and should discourage patients with previous MI [heart attack] from seeking this therapy with the hope of preventing subsequent cardiovascular events.”